Company Filing History:
Years Active: 2001-2008
Title: Okke Franssen: Innovator in Pharmaceutical Formulations
Introduction
Okke Franssen is a notable inventor based in Utrecht, Netherlands. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of stable solutions and controlled release systems. With a total of 3 patents to his name, Franssen's work has the potential to impact various medical applications.
Latest Patents
Franssen's latest patents include a stable pharmaceutical formulation of erythropoietin. This formulation utilizes tris-(hydroxymethyl)-aminomethane as a stabilizer, notably excluding amino acids or human serum albumin. Another significant patent involves a method for the preparation of microspheres containing colloidal systems. This invention focuses on microencapsulated colloidal systems, such as liposomes, which can serve as controlled release systems for delivering active ingredients in both in vivo and in vitro applications.
Career Highlights
Throughout his career, Okke Franssen has worked with various companies, including Octoplus B.V. and Biogenerix AG. His experience in these organizations has allowed him to refine his expertise in pharmaceutical innovations and contribute to advancements in the field.
Collaborations
Franssen has collaborated with notable professionals in his field, including Wilhelmus Everhardus Hennink and Stefan Arnold. These collaborations have further enriched his work and expanded the impact of his inventions.
Conclusion
Okke Franssen's contributions to pharmaceutical formulations demonstrate his innovative spirit and dedication to improving medical solutions. His patents reflect a commitment to advancing the field and enhancing the delivery of active ingredients in therapeutic applications.